Specialty
Electrophysiology devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
645
510(k), De Novo and PMA
Decisions, last 36 months
149
Recruiting device trials
60
Industry sponsored
Adverse event reports
245,224
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- 12SL Precision510(k)
Ge Medical Systems Information Technologies, Inc.
K261307 · Decided Nov 3, 2026 · 196 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
- iCOR Beat510(k)
K260383 · Decided Nov 2, 2026 · 270 days after receipt
Device type: Electrocardiograph, Ambulatory (Without Analysis) (MWJ) · Cardiology
- Kinetic Software Library510(k)
K260640 · Decided Oct 23, 2026 · 238 days after receipt
Device type: Electrocardiograph (DPS) · Cardiology
K263319 · Decided Oct 21, 2026 · 30 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
K260801 · Decided Oct 16, 2026 · 219 days after receipt
Device type: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) (MWI) · Cardiology
K260676 · Decided Oct 14, 2026 · 226 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
K260005 · Decided Oct 5, 2026 · 276 days after receipt
Device type: Electrocardiograph (DPS) · Cardiology
K260250 · Decided Sep 29, 2026 · 245 days after receipt
Device type: Electrocardiograph (DPS) · Cardiology
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 5 | 0 | 1 |
| Jan 24 | 1 | 0 | 2 |
| Feb 24 | 2 | 0 | 1 |
| Mar 24 | 3 | 0 | 0 |
| Apr 24 | 6 | 0 | 0 |
| May 24 | 2 | 0 | 0 |
| Jun 24 | 9 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 |
| Aug 24 | 5 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 |
| Oct 24 | 3 | 1 | 1 |
| Nov 24 | 2 | 0 | 1 |
| Dec 24 | 4 | 0 | 0 |
| Jan 25 | 6 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 |
| Apr 25 | 2 | 0 | 3 |
| May 25 | 3 | 0 | 0 |
| Jun 25 | 4 | 0 | 0 |
| Jul 25 | 6 | 0 | 1 |
| Aug 25 | 2 | 0 | 1 |
| Sep 25 | 3 | 0 | 0 |
| Oct 25 | 2 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 |
| Dec 25 | 5 | 0 | 1 |
| Jan 26 | 4 | 0 | 2 |
| Feb 26 | 2 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 |
| Apr 26 | 6 | 0 | 0 |
| May 26 | 4 | 0 | 0 |
| Jun 26 | 6 | 0 | 0 |
| Jul 26 | 3 | 0 | 1 |
| Aug 26 | 7 | 0 | 0 |
| Sep 26 | 6 | 0 | 1 |
| Oct 26 | 5 | 0 | 0 |
| Nov 26 | 2 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyPivotal-lookingRecruiting
AtaCor Medical, Inc.Not on our public-company list
NCT07324031 · 280 participants (planned) · Start Jul 2, 2026 · Primary completion Aug 31, 2027
Device: Atala™ lead and EV-ICD Pulse Generator · For: Ventricular Arrythmia; Ventricular Fibrillation; Ventricular Tachycardia
Sites: Scottsdale, Arizona; Jonesboro, Arkansas; La Jolla, California · 35 sites in all
- PULSED AF Post-Approval StudyRecruiting
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT06578104 · 580 participants (planned) · Start Nov 4, 2024 · Primary completion Apr 30, 2027
Device: PulseSelect™ PFA system · For: Atrial Fibrillation
Sites: Huntsville, Alabama; Clermont, Florida; Tampa, Florida · 29 sites in all
- VT Ablation in the iCMRRecruiting
Imricor Medical SystemsNot on our public-company list
NCT05543798 · 64 participants (planned) · Start Apr 10, 2025 · Primary completion Jul 2027
Device: Vision-MR Ablation Catheter 2.0 · For: Ventricular Tachycardia
Sites: Leipzig, Germany; Amsterdam, Netherlands; The Hague, Netherlands
Biosense Webster, Inc.Public (JNJ)
NCT07227532 · 276 participants (planned) · Start Oct 21, 2025 · Primary completion Dec 31, 2030
Device: Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator · For: Atrial Fibrillation
Sites: Phoenix, Arizona; Tucson, Arizona; Fountain Valley, California · 25 sites in all
Biosense Webster, Inc.Public (JNJ)
NCT07845682 · 150 participants (planned) · Start Oct 14, 2026 · Primary completion Apr 17, 2028
Device: Radiofrequency/Pulsed Field Ablation · For: Atrial Fibrillation
Sites: Beijing, China; Jinan, China; Nanjing, China · 4 sites in all
Biosense Webster, Inc.Public (JNJ)
NCT07116525 · 90 participants (planned) · Start Sep 15, 2025 · Primary completion Feb 7, 2027
Device: Paddle-Shaped, High-Density, Multi-Electrode Mapping Catheter · For: Scar-related Atrial Tachycardia; Persistent Atrial Fibrillation; Paroxysmal Atrial Fibrillation and 6 more
Sites: Bruges, Belgium; Hasselt, Belgium; Pessac, France · 5 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
245,224
Received Nov 1, 2025 to Nov 19, 2026. Includes 621 of another or unstated type.
Malfunction reports
170,772
70% of reports
Injury reports
71,591
29% of reports
Death reports
2,240
0.9% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 10,407 | 5,826 | 202 | 0 |
| Dec 25 | 11,329 | 6,082 | 206 | 1 |
| Jan 26 | 9,134 | 6,227 | 196 | 2 |
| Feb 26 | 11,492 | 6,238 | 209 | 0 |
| Mar 26 | 18,835 | 6,696 | 201 | 1 |
| Apr 26 | 19,170 | 6,378 | 165 | 2 |
| May 26 | 15,144 | 6,076 | 218 | 0 |
| Jun 26 | 17,018 | 6,004 | 207 | 0 |
| Jul 26 | 16,929 | 5,782 | 163 | 7 |
| Aug 26 | 11,070 | 5,096 | 155 | 85 |
| Sep 26 | 14,671 | 5,666 | 169 | 175 |
| Oct 26 | 15,573 | 5,520 | 149 | 348 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- CareLink SmartSync Programmer, Model 24970A, Pulse generator, permanent, implantableOpen, Classified
Z-0302-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
- CareLink SmartSync, RF Head Patient Connector, Model 24967, Pulse generator, permanent, implantableOpen, Classified
Z-0303-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
- CareLink SmartSync Device Manager App, Model M01A02, Pulse generator, permanent, implantableOpen, Classified
Z-0304-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
Z-0285-2027 · Started Sep 17, 2026 · Posted by FDA Oct 23, 2026
Reason given: Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.
Cause as FDA categorized it: Process design · Device type: Permanent Defibrillator Electrodes (NVY)
Z-0199-2027 · Started Sep 16, 2026 · Posted by FDA Oct 16, 2026
Reason given: Unreliable wireless roaming behavior of Smart-hopping 1.0 wireless clients during transport when connecting to Smart-hopping 2.0 infrastructure, resulting in loss of connectivity to the central monitoring system (PIC iX).
Cause as FDA categorized it: Software design · Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX)
Z-0089-2027 · Started Sep 8, 2026 · Posted by FDA Oct 6, 2026
Reason given: Due to a cybersecurity issue associate with a NULL Pointer Dereferences vulnerabiity. If exploited would potentially cause disruption of the centralized monitoring of multiple beds and the visualization of alarms.
Cause as FDA categorized it: Software design · Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX)
- ePM Series Patient Monitor. Patient Monitor Series: ePM 10M/ePM 12M/ePM 12MA/ ePM 15M/ePM 10AOpen, Classified
Z-0109-2027 · Started Aug 31, 2026 · Posted by FDA Oct 7, 2026
Reason given: Certain monitor operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions
Cause as FDA categorized it: Labeling design · Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX)
Z-0110-2027 · Started Aug 31, 2026 · Posted by FDA Oct 7, 2026
Reason given: Certain monitor operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions
Cause as FDA categorized it: Labeling design · Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX)
Showing the 8 newest of 1,872 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.